Paul Tudor Jones No Chance of Rate Cuts Under Potential Fed Chair Kevin Warsh Examining the Escalating Cost of Homeownership in the US AI Reshapes Labor Market BlueCollar Skilled Trades Gain as WhiteCollar Entry Jobs Slow Inflation Rate Could Reach 6 in Q2 According to Economic Forecasters SpaceX IPO Valuation Balancing Phenomenal Achievements with Market Hype UKGulf Trade Agreement Hailed as Monumental Achievement by Bahrain Minister PSO Q4 2025 Earnings Modest EPS Beat Highlights Steady Execution Day One Biopharmaceuticals Q4 2025 Earnings EPS Miss Amid Continued RD Investment TWFG Q1 2026 Earnings Strong EPS Beat Drives Investor Attention Despite Slight Stock Decline TSHA Q1 2026 Earnings EPS Misses Estimates as Company Advances Gene Therapy Pipeline CurtissWright Corporation CW Q1 2026 Earnings Earnings Beat Lifts Shares Amid Steady Operational Execution BLNK Q1 2026 Earnings Narrowing Loss Beats Expectations Stock Rises Alerus Financial ALRS Sees Modest Decline Amidst Broader Financial Sector Pressures The Brand House Collective TBHC Holds Steady Consolidation Near Key Resistance Blue Gold Limited Warrant BGLWW Jumps 8 as Speculative Interest Intensifies Opendoor Technologies OPEN Surges 10 Volumes Signal Renewed Investor Interest Wayfair W Surges 52 as Home Goods Sector Shows Renewed Momentum Indian Rupee Rebounds Past 96 on Strong RBI Intervention PLOW Q1 2026 Earnings Earnings Surge 161 Above Estimates as Profitability Surprises Cohen Steers REIT and Preferred Income Fund RNP Stabilizes Near 2080 as Market Digests Modest Decline Cadiz Inc Depositary Shares CDZIP Edge Lower in Quiet Trading Key Support Holds Near 1947 Genenta Science GNTA Holds Steady at 060 Amid Low Volatility NexPoint Residential Trust NXRT Posts Modest Uptick Amid Steady Multifamily Demand Gesher Acquisition Corp II GSHR Shares Inch Higher as SPAC Hovers Near Trust Value Grupo Financiero Galicia GGAL Surges 54 Argentine Bank Breaks Higher on Volume Sunstone Hotel Investors SHO Rises 193 as Hospitality Sector Shows Signs of Stabilization BristolMyers Squibb BMY Sees Modest Decline Holds Above Key Support